Skip to main content
. 2021 Feb 16;59(5):529–537. doi: 10.1038/s41393-021-00616-6

Table 1.

Demographical information and basic information on clinical pain.

Subj. Nr. Age Sex
[f = female, m = male]
NLI AIS grade Etiology
[1 = traumatic, 2 = non-traumatic]
Time since injury [years] Pain onset after injury [months] Pain duration [years] Pain intensity [NRS 0–10] Presence of MSK Presence of at-level NP Pain medication
1 52 f T10 A 1 23.4 <6 23 3 No Yes
2 55 m T1 A 1 11.8 <12 11 3 No No PGB
3 35 m T11 C 1 14.5 <6 14 4 Yes Yes CB, PCM, MMZ
4 53 m T5 A 1 20.4 <6 20 3 No No
5 75 f T10 A 2 14.4 <1 15 7 Yes Yes PGB, GPT
6 59 m T9 D 1 6.7 <1 7 1 Yes Yes
7 58 m T11 A 2 24.1 <1 24 6 No Yes ATD, CBZ
8 62 m T11 C 1 8.8 <1 9 8 Yes Yes ATD, PGB, CB
9 36 m T11 A 1 6.7 <1 7 6 No Yes PGB, Voltaren
10 75 m T10 D 2 13.8 <1 14 7 Yes Yes NA
11 62 m T11 A 1 36.3 <3 36 5 Yes Yes
12 66 m T3 D 1 19.1 <1 19 8 No No
13 57 m T2 A 1 3.8 <1 4 5 Yes Yes ATD, PGB, CB
14 61 m T8 D 2 11 <1 11 5 Yes No
15 63 m T12 A 1 16.8 <2 17 3 No No
16 62 m T1 D 1 36.4 ~24 13 4 No No
17 50 m T3 D 2 21.3 <3 21 5.5 No No
18 54 m T10 C 1 13.3 <3 13 7 Yes Yes PGB, PCM
19 59 m T12 C 1 37.6 >24 11 9 Yes No
20 54 f T5 D 2 6.2 <3 6 3 No No AT, MMZ

NLI neurological level of injury, AIS ASIA Impairment Scale, MSK musculoskeletal pain, NP neuropathic pain, PGB pregabalin, CB cannabinoids, PCM paracetamol, MMZ metamizol, GPT gabapentin, ATD antidepressants, AT amitriptyline.